TRAF2 and neoplasm: Although current studies have primarily focused on improving anti-tumor responses through perturbations of TNF receptors (i.e., TNF receptor complex 1, TRAF2, and TRAIL receptors), future investigations should also explore the intracellular downstream signaling cascades.50